BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9655168)

  • 1. Vancomycin-resistant enterococci and empirical vancomycin for CAPD peritonitis.
    Sandoe JA; Gokal R; Struthers JK
    Perit Dial Int; 1997; 17(6):617-8. PubMed ID: 9655168
    [No Abstract]   [Full Text] [Related]  

  • 2. VRE and empirical vancomycin for CAPD peritonitis: use at your own/patient's risk.
    Vas SI
    Perit Dial Int; 1998; 18(1):86-7. PubMed ID: 9527040
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) with co-trimoxazole, cefazolin or vancomycin].
    König U; Müller U; Binswanger U
    Klin Wochenschr; 1987 Jul; 65(12):562-70. PubMed ID: 3498086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of peritonitis treated with intraperitoneal (i.p.) weekly vancomycin and i.p. daily netilmicin.
    Chadwick DH; Agarwal S; Vora BJ; Hair M; McKewan A; Gokal R
    J Nephrol; 1999; 12(5):318-21. PubMed ID: 10630696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal teicoplanin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis.
    Bowley JA; Pickering SJ; Scantlebury AJ; Ackrill P; Jones DM
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():133-9. PubMed ID: 2965125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized prospective comparison of oral levofloxacin plus intraperitoneal (IP) vancomycin and IP netromycin plus IP vancomycin as primary treatment of peritonitis complicating CAPD.
    Cheng IK; Fang GX; Chau PY; Chan TM; Tong KL; Wong AK; Li CS; Lo WK; Cheung KO; Kumana CR
    Perit Dial Int; 1998; 18(4):371-5. PubMed ID: 10505557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAPD peritonitis caused by vancomycin-resistant lactobacilli.
    Rao GG; Short A; Carmichael DJ
    Nephrol Dial Transplant; 1990; 5(3):235-6. PubMed ID: 2113654
    [No Abstract]   [Full Text] [Related]  

  • 8. Vancomycin-resistant enterococcus infection is a rare complication in patients receiving PD on an outpatient basis.
    Ng R; Zabetakis PM; Callahan C; Krapf R; Sasak C; Fritzsch S; Pollock A; Balter P; Michelis MF
    Perit Dial Int; 1999; 19(3):273-4. PubMed ID: 10433167
    [No Abstract]   [Full Text] [Related]  

  • 9. Lactobacillus paracasei continuous ambulatory peritoneal dialysis-related peritonitis and review of the literature.
    Neef PA; Polenakovik H; Clarridge JE; Saklayen M; Bogard L; Bernstein JM
    J Clin Microbiol; 2003 Jun; 41(6):2783-4. PubMed ID: 12791931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin and tobramycin in the treatment of CAPD peritonitis.
    Gruer LD; Turney JH; Curley J; Michael J; Adu D
    Nephron; 1985; 41(3):279-82. PubMed ID: 4058628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of antibiotics used to treat peritoneal dialysis-associated peritonitis.
    Johnson CA; Zimmerman SW; Rogge M
    Am J Kidney Dis; 1984 Jul; 4(1):3-17. PubMed ID: 6377882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emergence of vancomycin resistance in renal dialysis.
    Sanyal D; Williams AJ; Johnson AP; George RC
    J Hosp Infect; 1993 Jul; 24(3):167-73. PubMed ID: 8104207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
    Fenton P
    J Antimicrob Chemother; 1984 May; 13(5):411-3. PubMed ID: 6735960
    [No Abstract]   [Full Text] [Related]  

  • 14. Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis.
    Wong KM; Chan YH; Cheung CY; Chak WL; Choi KS; Leung SH; Leung J; Chau KF; Tsang DN; Li CS
    Am J Kidney Dis; 2001 Jul; 38(1):127-31. PubMed ID: 11431192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin treatment of bacterial peritonitis associated with chronic ambulatory peritoneal dialysis caused by Neisseria cinerea.
    Taegtmeyer M; Saxena R; Corkill JE; Anijeet H; Parry CM
    J Clin Microbiol; 2006 Aug; 44(8):3040-1. PubMed ID: 16891538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAPD peritonitis caused by Lactobacillus rhamnosus.
    Sanyal D; Bhandari S
    J Hosp Infect; 1992 Dec; 22(4):325-7. PubMed ID: 1363113
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of once-weekly vancomycin and once-daily gentamicin, intraperitoneally, for CAPD peritonitis.
    Bailie GR; Haqqie SS; Eisele G; Gorman T; Low CL
    Perit Dial Int; 1995; 15(6):269-71. PubMed ID: 7578507
    [No Abstract]   [Full Text] [Related]  

  • 18. Peritonitis due to Comamonas acidovorans in a CAPD patient.
    López-Menchero R; Sigüenza F; Caridad A; Alonso JC; Ferreruela RM
    Perit Dial Int; 1998; 18(4):445-6. PubMed ID: 10505573
    [No Abstract]   [Full Text] [Related]  

  • 19. Vancomycin therapy for treatment of peritonitis in outpatients on peritoneal dialysis.
    Yorioka N; Taniguchi Y; Ito T; Katsutani M; Amimoto D; Masaki T; Nishida Y; Kushihata S; Oda H; Yamakido M
    Hiroshima J Med Sci; 1998 Sep; 47(3):105-7. PubMed ID: 9810781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin-dependent enterococci in a uraemic patient with sclerosing peritonitis.
    Majumdar A; Lipkin GW; Eliott TS; Wheeler DC
    Nephrol Dial Transplant; 1999 Mar; 14(3):765-7. PubMed ID: 10193837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.